NIH-funded research R21 grant

Understanding how specific genes affect brain function in autism

Official title: Investigating the Translatome in Genetic Models of Autism

Funded at Yale University · NIH-10824339 · Data updated 2026-11-12

This study is looking at how certain genes related to autism, called CHD8 and SCN2A, affect brain development using zebrafish, which could help us find new ways to support people with autism.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startApril 15, 2023
Project endSeptember 30, 2025
Funding year2024
Award (this year)$208,342
NIH project number5R21MH133245-02
Project IDNIH-10824339 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with autism spectrum disorders or those with a family history of ASD.

Less likely to help

Patients with autism spectrum disorders not linked to the genes CHD8 or SCN2A may not benefit from this research.

What this research studies

This research investigates the biological mechanisms underlying autism spectrum disorders (ASDs) by focusing on two key genes, CHD8 and SCN2A, using zebrafish models. The study employs advanced genomic technologies to analyze how the loss of function of these genes impacts translation regulation in the developing brain, particularly in neurons and glial cells. By utilizing techniques like Translating Ribosome Affinity Purification sequencing and single-cell RNA sequencing, the research aims to uncover cell type-specific deficits associated with ASD. This could lead to new insights into potential therapeutic targets for autism.

Why it matters

Potential benefit: If successful, this research could identify new therapeutic targets for treating autism spectrum disorders.

How similar studies have gone: Previous research has shown promising results in understanding gene functions related to autism, making this approach a continuation of successful methodologies.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Hoffman, Ellen J — Yale University
  • Study coordinator: Hoffman, Ellen J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.